Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
All of these medications belong to the same drug family but are approved for different conditions
GLP-1s and Addiction The authors of GLP-1 Therapeutics and Their Emerging Role in Alcohol and Substance Use Disorders: An Endocrinology Primer , appearing in October 2025 in JES, point out that the World Health Organization reported 890 million adults and 60 million children and adolescents had obesity in 2022 globally
Background Substance use disorder is a leading public health concern, affecting approximately 40 million people worldwide
Besides protective effects on substance use disorders, the authors analyzed the impact of GLP-1 receptor agonists on body weight management, body mass index (BMI), and glycated hemoglobin level (a measure of glycemic control)
I knew my body would do what it was supposed to do
This is important news because it means these medications can help a wide range of patients achieve their health goals
US$ 27.09
US$ 28.18
US$ 25.53
US$ 27.45
